The question is why these mutations (in BRCA1 and BRCA2, etc.)yield increased risks of cancer in a tissue-specific manner (breast, ovary, and to a much lesser extent, pancreas, prostate, etc.), whereas the genes themselves, both BRCA1 and BRCA2, are expressed ubiquitously, with any predilection for certain tissues. Here, BRCA1 is linked to cancer.